Medical News

RSS

Insight into molecular basis of Enhanced S-Cone Syndrome

A new research report published in The FASEB Journal will help ophthalmologists and scientists better understand a rare genetic disease that causes increased susceptibility to blue light, night blindness, and decreased vision called Enhanced S-Cone Syndrome or Goldman-Favre Syndrome.

2 Sep 2011

UTHealth to study BMS-820836 in Phase II trial for major depressive disorder

A new medication to treat major depressive disorder in patients who have not responded to other antidepressants is being studied in a Phase II clinical trial by researchers at The University of Texas Health Science Center at Houston.

2 Sep 2011

Medtronic initiates U.S. post-approval study of Endurant AAA Stent Graft System

Leading the development of endovascular aortic repair (EVAR), Medtronic, Inc. today announced the start of its U.S. post-approval study of the Endurant AAA Stent Graft System, a medical device used to treat abdominal aortic aneurysms.

From Medtronic 2 Sep 2011

Tobacco industry goes after confidential smoking data from UK’s Department of Health

The tobacco giants are urging the UK’s Department of Health to extract information about meetings between government officials and researchers who are investigating the public-health implications of new smoking policies.

2 Sep 2011

Eclipse extends tender offer to acquire Icagen for $6.00 per share

Pfizer Inc. and Icagen, Inc. announced today that Pfizer's wholly-owned subsidiary, Eclipse Acquisition Corp., has extended the expiration date of its tender offer for all outstanding shares of common stock of Icagen for $6.00 per share, paid to the seller in cash, without interest thereon, less any applicable withholding and transfer taxes.

2 Sep 2011

Low-cost, portable technique can detect specific proteins in human blood

Blood tests are important diagnostic tools. They accurately tease-out vanishingly small concentrations of proteins and other molecules that help give a picture of overall health or signal the presence of specific diseases. Current testing procedures, however, are expensive and time-consuming, while sophisticated test equipment is bulky and difficult to transport.

2 Sep 2011

HIV/AIDS policies “woefully inadequate” in Britain: Report

AIDS and HIV prevention policies in Britain are “woefully inadequate” and must be improved, a House of Lords committee warned today. The report by the Lord Select Committee is published on the 25th anniversary of the 'Don't Die of Ignorance' campaign, a public health initiative launched to try to stem the spread of the virus.

2 Sep 2011

Engineered virus shows promise in cancer therapy via bloodstream

Scientists have engineered a virus that when injected into the blood, can selectively target cancer cells throughout the body. The virus attacked only tumours, leaving the healthy tissue alone, in a small trial on 23 patients, according to the journal Nature.

2 Sep 2011

LCA applauds FDA approval of Xalkori for ALK positive non-small cell lung cancer

Lung Cancer Alliance (LCA) applauds the Food and Drug Administration (FDA) approval of Xalkori (crizotinib) with non-small cell lung cancer (NSCLC) who are ALK positive. The drug was approved based on data from two clinical trials, both of which showed a significant increase in overall survival.

2 Sep 2011

Tamiflu resistant flu found in Newcastle, Australia

The influenza pandemic has gathered a lot of action, advice and coverage over the last few years. In 2009, an international H1N1 influenza pandemic led to concerns that there would be a repeat of the 1918 influenza pandemic which resulted in millions of deaths worldwide. The World Health Organization recorded over 37,000 cases of the H1N1 pandemic influenza in Australia and 193 confirmed deaths.

2 Sep 2011

Medtronic acquires PEAK and Salient

Medtronic, Inc. today announced that it has completed the acquisition of two privately-held companies, PEAK Surgical, Inc. and Salient Surgical Technologies, Inc. Both of the companies are focused on advanced energy surgical technologies and will broaden Medtronic Surgical Technologies' portfolio of innovative surgical products to meet customer and patient needs worldwide.

From Medtronic 2 Sep 2011

MRSA ‘superbug’: Everyone at risk!

Methicillin-resistant Staphylococcus aureus (MRSA), a type of staph bacteria that does not respond to commonly used antibiotic treatments, is a type of infection that has been a problem in hospital settings for many years. Back in 2000 it began steadily making its way into the lives of otherwise healthy people, especially children, who are not typically at risk for the fast-moving bacteria.

2 Sep 2011

Eating potatoes good for lowering blood pressure, also no weight gain

A new study refutes previous knowledge that potatoes lead to excessive weight gain. The study claims that eating ‘spuds’ daily can help lower your blood pressure; and moreover, there is also no weight gain involved.

2 Sep 2011

Viewpoints: Barrasso on employer insurance; Oberlander on austerity, Jennings on 'pick your poison'; Lamm on your mother

Most American workers value their employer-provided health insurance. It gives them the security of knowing they can get the care they need, from the doctor they want, at a price they can afford. All that will change drastically if the president's health care law remains on the books.

2 Sep 2011

FDA may be allowed an extra 2 months to review new drugs

The deadline for approval or rejection of new drugs by the Food and Drug Administration (FDA) could be extended by two months say U.S. regulators and drug industry officials.

2 Sep 2011

9/11 firefighters at greater risk of cancer

A new study shows that firefighters who were exposed to toxic dust and fumes clogging the air after the World Trade Center towers collapsed 10 years ago are more likely to develop cancer.

2 Sep 2011

Longer CPR may do more harm than good: Study

A new study reveals that providing CPR (cardiopulmonary resuscitation) for a longer period of time could actually harm certain patients. “We found that extra CPR didn't help and, in fact, in some patients it was not a good thing. It would make it worse,” said Dr. Ian Stiell, lead author of a paper published in the Sept. 1 issue of the New England Journal of Medicine. “Our study showed that there's no reason to do two minutes of CPR or to delay defibrillation.”

31 Aug 2011

Bowel cancer, coffee and diabetes: Two new studies

Australian researchers have identified a link between type 2 diabetes in men and a significantly increased risk of bowel cancer, triggering calls for diabetics to have regular checks.

31 Aug 2011

Further acne treatment studies necessary: Experts

Researchers writing in the journal The Lancet suggest further research that is urgently needed for effective non-antibiotic treatments for acne, because of concerns regarding long-term antibiotic use and its contribution to bacterial resistance. Pharmacies are well stocked with a wide range of acne medications. However, evidence regarding their efficacy and which treatments work best for whom are limited, the authors added.

31 Aug 2011

Sunscreen pills from coral

Researchers have found that coral does not suffer from sunburn despite living in shallow water in tropical areas, because it is able to produce its own “natural sunscreen”. By studying the compounds which protect it from UV rays, researchers hope to develop a tablet which can protect human skin and eyes without the need for dark glasses or sun cream. Scientists from King's College London said the first sunscreen pill could be available within five years.

31 Aug 2011